Published date: Jun 28 2024

Journal Title: West Kazakhstan Medical Journal

Issue title: West Kazakhstan Medical Journal: Volume 66 Issue 2

Pages: 176–179

DOI: 10.18502/wkmj.v66i2.16464

Eyüp Murat YilmazDepartment of General Surgery, Nev Health Group Hospital, Bursa, Turkey

Erkan KaracanDepartment of General Surgery, Karabuk University Hospital, Karabuk, Turkey

Objective To compare the results of the lateral internal sphincterotomy(LIS) technique and high dose botulinum toxin, which is one of the treatments applied when medical treatment is insufficient in anal fissure. Materials and methods The files and outpatient clinic notes of the patients who underwent lateral internal sphincterotomy and botulinum toxin injection due to lack of response to medical treatment due to anal fissure between May 2020 and May 2023 were examined retrospectively. Preoperative and postoperative visual analog scale (VAS) scores, five-point horizontal scale (FPHS) scores, hospitalization times, fissure locations, follow-up periods, anesthesia type, and postoperative complications of the patients were recorded. Results Total 30 LIS and 24 botulinum toxin-treated patients were included. Hospitalization time was shorter in botulinum toxin groups than in the LIS group (p<0.001). First-week VAS score was lower than botulinum toxin injection group (p<0.001). There was no significant difference between the groups in terms of FPHS scores, follow-up periods, and recurrence (p:0.15, p:0.07, p:0.14). Conclusion: While LIS is faster in the early period, botulinum toxin injection can be considered as an alternative to surgical treatment for long-term results.

Keywords: anal fissure, sphincterotomy, botox

[1] Beaty JS, Shashidharan M. Anal fissure. Clin Colon Rectal Surg. 2016;29:30–7.

[2] B.B. Mentes, T. Tezcaner, U. Yılmaz, S. Leventoğlu, M. Oguz. Results of lateral internal sphincterotomy for chronic anal fissure with particular reference to quality of life. Dis Colon Rectum. 2006;49:1045-1051

[3] Boland PA, Kelly ME, Donlon NE, Bolger JC, Larkin JO, Mehigan BJ, McCormick PH. Management options for chronic anal fissure: a systematic review of randomised controlled trials. International Journal of Colorectal Disease. 2020;35:1807-15.

[4] Ooijevaar RE, Felt-Bersma RJF, Han-Geurts IJ, van Reijn D, Vollebregt PF, Molenaar CBH. Botox treatment in patients with chronic functional anorectal pain: Experiences of a tertiary referral proctology clinic. Tech Coloproctol.2019;23:239–44. doi: 10.1007/s10151-019-01945-8

[5] Çakır C, Idiz UO, Aydın I, Fırat D, Ulusaoy Aİ, Yazıcı P. Comparison of the e￿ectiveness of two treatment modalities for chronic anal fissure: Botox versus sphincterotomy. Turk J Surg. 2020; 36 (3): 264-270.

[6] Al-thoubaity F. Safety and efficacy of the treatment of chronic anal fissure by lateral internal sphincterotomy: A retrospective cohort study. Ann Med Surg. 2020; 57: 291–294.

[7] Acar T, Acar N, Güngör F, Kamer E et al. Treatment of chronic anal fissure: Is open lateral internal sphincterotomy (LIS) a safe and adequate option? Asian Journal of Surgery. 2019;42:5 628-633.

[8] Nelson RL, Thomas K, Morgan J, Jones A. Nonsurgical therapy for anal fissure. Cochrane Database Syst Rev. 2012;15:2